Melphalan 50 MG Injection — RxCUI 311487
RxNorm drug concept · Semantic clinical drug
RxCUI 311487
Semantic clinical drug · SCD
● Current RxNorm concept 15 FDA products
18 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI311487
Official nameMelphalan 50 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmelphalan (as melphalan hydrochloride) 50 MG Injection
FDA products mapped15
Package NDCs mapped18
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Melphalan Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Evomela, an IV melphalan product, is used before a stem cell transplant in people with multiple myeloma. It is high-dose chemotherapy that prepares your body for the transplant.
- It is given through a vein by a healthcare professional. Sometimes a central line is used to protect your veins and surrounding tissue. Your team will follow your prescriber's plan...
- Common ones are low blood counts, nausea, vomiting, diarrhea, tiredness, low potassium and mouth sores. Your team may give you medicines to help with nausea and diarrhea.
- Call right away for fever or signs of infection, unusual bleeding or bruising, severe diarrhea or vomiting, or yellowing of your skin or eyes. Get emergency help for hives, swellin...
🕸️ Concept Web — How Melphalan 50 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Melphalan 50 MG Injection
RxCUI 311487 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Melphalan
6718IN
-
Melphalan
-
Brand names 3
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Alkeran
151325BN -
Evomela
1745086BN -
Hepzato
2671192BN
-
Alkeran
-
Dose forms 10
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Melphalan Injection
1740949SCDF -
Melphalan Injectable Product
1159787SCDG -
Melphalan Injection [Alkeran]
1740952SBDF -
Melphalan Injection [Evomela]
1745088SBDF -
Melphalan Injection [Hepzato]
2671195SBDF -
Alkeran Injectable Product
1176189SBDG -
Evomela Injectable Product
1745089SBDG -
Hepzato Injectable Product
2671194SBDG - +2 more in this family
-
Melphalan Injection
-
Clinical & branded drugs 7
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Melphalan 50 MG
1740948SCDC -
Melphalan 50 MG Injection [Alkeran]
876399SBD -
Melphalan 50 MG Injection [Evomela]
1745090SBD -
Melphalan 50 MG Injection [Hepzato]
2671196SBD -
Melphalan 50 MG [Alkeran]
1740951SBDC -
Melphalan 50 MG [Evomela]
1745087SBDC -
Melphalan 50 MG [Hepzato]
2671193SBDC
-
Melphalan 50 MG
Showing up to 8 concepts per family — 19 of 21 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Melphalan 50 MG
SCDC · 1740948 -
Melphalan Injection
SCDF · 1740949 -
Melphalan Injectable Product
SCDG · 1159787
Brand-Name Concepts
-
Melphalan 50 MG Injection [Evomela]
SBD · 1745090 -
Melphalan 50 MG Injection [Hepzato]
SBD · 2671196 -
Melphalan 50 MG Injection [Alkeran]
SBD · 876399 -
Melphalan 50 MG [Alkeran]
SBDC · 1740951 -
Melphalan 50 MG [Evomela]
SBDC · 1745087 -
Melphalan 50 MG [Hepzato]
SBDC · 2671193 -
Melphalan Injection [Alkeran]
SBDF · 1740952 -
Melphalan Injection [Evomela]
SBDF · 1745088 -
Melphalan Injection [Hepzato]
SBDF · 2671195 -
Alkeran Injectable Product
SBDG · 1176189
📦 FDA Products & Package NDCs
15 products · 18 package NDCs
18 package NDCs map to RxCUI 311487 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 25021-0258-61 | 1 KIT in 1 CARTON (25021-258-61) * 10 mL in 1 VIAL (25021-... | Melphalan Hydrochloride | Sagent Pharmaceuticals | 2024-04-01 |
| 31722-0362-31 | 1 KIT in 1 CARTON (31722-362-31) * 10 mL in 1 VIAL, SINGLE... | MELPHALAN HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 2024-05-23 |
| 43598-0392-48 | 1 KIT in 1 CARTON (43598-392-48) * 10 mL in 1 VIAL, SINGLE... | Melphalan Hydrochloride | Dr.Reddy's Laboratories Inc | 2017-12-18 |
| 54288-0109-02 | 1 KIT in 1 CARTON (54288-109-02) * 10 mL in 1 VIAL, SINGLE... | Melphalan hydrochloride | BPI Labs LLC | 2021-07-02 |
| 63323-0760-20 | 1 KIT in 1 CARTON (63323-760-20) * 10 mL in 1 VIAL, SINGLE... | Melphalan | Fresenius Kabi USA, LLC | 2017-12-22 |
| 67184-0618-02 | 1 KIT in 1 CARTON (67184-0618-2) * 15 mL in 1 VIAL, SINGLE... | Melphalan Hydrochloride | Qilu Pharmaceutical Co., Ltd. | 2023-12-18 |
| 67457-0195-01 | 1 KIT in 1 CARTON (67457-195-01) * 10 mL in 1 VIAL, GLASS... | Melphalan Hydrochloride | Mylan Institutional LLC | 2013-01-10 |
| 68083-0259-01 | 1 KIT in 1 CARTON (68083-259-01) * 10 mL in 1 VIAL, SINGLE... | Melphalan hydrochloride | Gland Pharma Limited | 2019-06-10 |
| 71288-0132-90 | 1 KIT in 1 CARTON (71288-132-90) * 15 mL in 1 VIAL, SINGLE... | Melphalan hydrochloride | Meitheal Pharmaceuticals Inc. | 2021-05-28 |
| 72266-0128-01 | 1 KIT in 1 CARTON (72266-128-01) * 10 mL in 1 VIAL, SINGLE... | Melphalan hydrochloride | Fosun Pharma USA Inc | 2019-09-23 |
| 72893-0001-01 | 1 VIAL in 1 CARTON (72893-001-01) / 20 mL in 1 VIAL | EVOMELA | Acrotech Biopharma Inc | 2016-03-31 |
| 75833-0601-01 | 1 KIT in 1 BOX (75833-601-01) * 5 VIAL, SINGLE-USE in 1 BO... | Hepzato Kit | Delcath Systems, Inc. | 2023-12-04 |
| 75833-0601-02 | 1 KIT in 1 BOX (75833-601-02) * 5 VIAL, SINGLE-USE in 1 BO... | Hepzato Kit | Delcath Systems, Inc. | 2023-12-04 |
| 75833-0601-07 | 1 KIT in 1 BOX (75833-601-07) * 5 VIAL, SINGLE-USE in 1 BO... | Hepzato Kit | Delcath Systems, Inc. | 2023-12-04 |
| 75833-0601-08 | 1 KIT in 1 BOX (75833-601-08) * 5 VIAL, SINGLE-USE in 1 BO... | Hepzato Kit | Delcath Systems, Inc. | 2023-12-04 |
| 75907-0112-11 | 1 KIT in 1 CARTON (75907-112-11) * 10 mL in 1 VIAL, SINGLE... | Melphalan Hydrochloride | Dr.Reddy's Laboratories Inc | 2024-06-26 |
| 83634-0202-61 | 1 KIT in 1 CARTON (83634-202-61) * 15 mL in 1 VIAL, SINGLE... | Melphalan Hydrochloride | Avenacy Inc. | 2023-12-18 |
| 84679-0001-01 | 1 KIT in 1 CARTON (84679-001-01) * 15 mL in 1 VIAL, SINGLE... | Melphalan Hydrochloride | Arthur Group LLC | 2024-11-30 |
Observed labelers:
Delcath Systems, Inc. (4) ·
Dr.Reddy's Laboratories Inc (2) ·
Acrotech Biopharma Inc (1) ·
Arthur Group LLC (1) ·
Avenacy Inc. (1) ·
BPI Labs LLC (1)
· +8 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9245 | Inj melpha hydroch nos 50 mg | 8 | CMS |
| J9248 | Inj melphalan (hepzato) 1 mg | 2 | CMS |
| J9246 | Inj., evomela, 1 mg | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.